MediOP™ – our
closed-loop platform.
Multus has reimagined media development from the ground up. Our MediOP™ platform combines high-throughput robotic automation, AI, and deep cell biology expertise to design and test cell culture media formulations at scale. Each round of experiments generates performance data that informs the next, allowing us to refine formulations around your cells and goals. This feedback loop puts data at the heart of our media design process.
One integrated system
for media design.
We turn cell culture media development into cell culture media design. Our MediOP™ platform allows us to design custom media tailored to your cells and process. We develop cell-specific formulations optimised for performance, cost, and quality, transforming years of guesswork into weeks of custom design.
Formulations designed for your cells
Our algorithm searches a vast space of possible formulations and selects promising candidates to test, based on your cells, goals, and ingredient constraints.
MediOP™ tests AI predictions
on real cells.
Verifying results through biology.
AI moves fastest when data is plentiful and easy to check, like language and images. Biology works differently. Data must come from real experiments, which are slow, expensive, and hard to repeat consistently, so AI can suggest far more ideas than any lab can test. Media development shows this problem clearly: labs test a handful of formulations at a time manually, and results rarely compare from one experiment to the next.
MediOP™ has a biological verifier integrated into the platform. Robotics make and grow the formulations the model suggests, and our automated imaging and analytics measure how the cells responded, consistently and reproducibly. Connecting AI to the lab like this is the hardest part to build, and it is the part we built first.
Each cycle adds to our dataset.
We own the world’s largest structured dataset on media performance, which is growing every day; each formulation we develop makes MediOP™ more powerful. This continuously expanding dataset enables our models to generalise performance patterns across cell lines and applications, delivering strong predictions even for cells we haven’t previously optimised.
Unlock the potential of cell-based biomanufacturing.
Advancing media projects across industries.